TherapeuticsMD Inc. (TXMD)
NASDAQ: TXMD
· Real-Time Price · USD
1.17
0.02 (1.72%)
At close: Aug 15, 2025, 3:58 PM
1.18
0.86%
After-hours: Aug 15, 2025, 07:44 PM EDT
TherapeuticsMD Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 551K | -653K | 114K | -567K | -1.09M | -809K | -1.54M | -1.43M | -2.41M | -2.31M | -33.22M | -28.96M | 112.28M | -49.02M | -42.96M | -47.42M | -42.65M | -39.38M |
Depreciation & Amortization | 96K | 95K | 100K | 96K | 180K | 133K | 637K | 129K | 129K | 27K | -1.99M | 1.03M | 1.05M | 1.1M | 1M | 1.03M | 1.04M | 1.02M |
Stock-Based Compensation | 1K | 23K | 24K | 33K | 96K | 111K | 116K | 234K | 438K | 483K | 2.98M | 4.31M | 2.22M | 2.06M | 5.35M | 7.31M | 2.51M | 2.96M |
Other Working Capital | n/a | 1.06M | 539K | -11K | 768K | 38K | -2.79M | -4.75M | -709K | -164K | -7.41M | -14.4M | 18.55M | -941K | -6.16M | -2.23M | 6.68M | 6.99M |
Other Non-Cash Items | -267K | 164K | -784K | 173K | 936K | 691K | -1.53M | 603K | -18K | -1K | 97M | 6.6M | -135.2M | 17.77M | 1.52M | 2.35M | 1.63M | 1.99M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -2.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | 95K | 215K | 230K |
Change in Working Capital | n/a | 1.06M | 563K | 80K | 772K | 150K | -3.46M | -5.56M | -1.53M | -6.9M | -5M | -1.9M | 4.25M | -1.44M | -4.46M | -1.59M | 10.73M | -5.19M |
Operating Cash Flow | 381K | 686K | 17K | -185K | 894K | 11K | -7.84M | -6.03M | -3.39M | -8.7M | 59.77M | -18.92M | -15.4M | -29.53M | -39.56M | -38.22M | -26.53M | -38.38M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -37K | -31K | -75K | -212K | -1.51M | -182K | -89K | -438K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -142.63M | n/a | 142.63M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 223.83M | -126K | 90K | -170K | -1.51M | -252K | -48K | -375K |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 81.16M | -31K | 142.56M | -212K | -1.51M | -182K | -89K | -438K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -94.43M | n/a | -120M | -5M | n/a | n/a | n/a | -50M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 2M | n/a | 1.15M | 1.11M | -2.29M | -715K | n/a | n/a | 119K | -131K | 265K | -4.95M |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | 2M | -1K | 1.15M | 1.11M | -111.94M | 1.74M | -120M | -5M | 1.35M | 31.82M | 428K | 95.95M |
Net Cash Flow | 324K | 686K | 12K | -185K | 894K | 11K | -5.84M | -3.56M | -3.52M | -32.07M | 10.99M | 777K | 7.17M | -34.74M | -39.72M | -6.58M | -26.19M | 57.13M |
Free Cash Flow | 381K | 699K | 17K | -71K | 894K | 11K | -7.84M | -6.03M | -3.39M | -8.7M | 59.73M | -18.95M | -15.48M | -29.74M | -41.07M | -38.41M | -26.62M | -38.82M |